Full-Time
Posted on 9/25/2025
Global contract services for drug lifecycle
No salary listed
Salt Lake City, UT, USA + 3 more
More locations: Las Vegas, NV, USA | Phoenix, AZ, USA | Portland, OR, USA
Hybrid
Candidates must be based in one of the listed cities.
Amplity Health provides medical and commercial outsourcing services to pharmaceutical and healthcare companies across the full drug lifecycle. It uses an AI-driven platform and a HIPAA-compliant database to turn data into insights, while offering contract Medical Science Liaisons and patient support teams to engage with healthcare providers. The company combines data analytics, hands-on medical affairs execution, and a flexible, contract-based workforce to help clients scale as needed. Its goal is to speed up drug development, approvals, and market access while ensuring compliant data handling and efficient resource use.
Company Size
1-10
Company Stage
Debt Financing
Total Funding
$102.5M
Headquarters
Santa Cruz, California
Founded
2010
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Peritia appoints Michael A. Griffith as Chief Executive Officer. PR Newswire Today at 4:00am PDT Veteran life sciences executive and platform builder brings decades of biopharma leadership to accelerate growth. MORRISVILLE, N.C. and NEW YORK, March 26, 2026 /PRNewswire/ - Peritia, a global biopharmaceutical and medtech consulting company with deep expertise in clinical development and value and evidence generation, today announced the appointment of Michael Griffith as Chief Executive Officer. Mr. Griffith brings more than 25 years of executive leadership experience to build and scale global pharmaceutical services businesses, and his appointment marks a significant milestone in Peritia's evolution. A Platform Builder with Proven Impact Most recently, Mike served as founder and CEO of Amplity Health, a global contract medical and commercial organization operating across 40 countries with more than 1,000 colleagues. Prior to Amplity, he served as Operating Partner at Altamont Capital Partners, where he led investments in biopharmaceutical outsourcing businesses, and as President of the Commercial Division of inVentiv Health, a leading global provider of biopharmaceutical outsourcing services across the research and commercialization continuum. His career also includes CEO stints at ChiRex, Aptuit, and Laureate Biopharma - each a recognized leader in contract drug development and manufacturing - as well as board service at Repligen Corporation and other public life sciences companies. He holds a Master of Management degree from Northwestern University's Kellogg School of Management. "As biopharma and medtech innovator funding continues to build, Peritia is exactly the kind of platform the industry needs right now - one that combines scientific depth, strategic advisory, and operational capability to our client engagements," said Mike Griffith. Peritia has successfully completed more than 1,100 engagements in 20 countries for 355 clients in the past five years. "Now we have the opportunity to scale the enterprise with purpose by building on the strong foundation that's already been established. Our goal is to be a trusted partner for biotech, pharma, and medtech innovators who require additional power to navigate clinical development and health economics." Griffith's appointment comes on the heels of Peritia's formal rebranding and consolidation of BioBridges, CHEORS, and Monitorforhire into a unified platform spanning corporate and product strategy, operational execution, and value, evidence, and access. His track record of building high-performance cultures and scaling life sciences service organizations positions him to accelerate Peritia's mission of guiding life sciences organizations from concept to commercialization. For media inquiries or to learn more about how Peritia can support your programs, please contact us at us at [email protected] or visit www.peritia.com, or visit our LinkedIn page at https://www.linkedin.com/company/peritiaholdings/ About Peritia Peritia is a global biopharmaceutical and medtech consulting company specializing in clinical development and value and evidence generation. We connect industry-leading talent with organizations across the life sciences ecosystem to help bring innovations to patients efficiently and effectively. In the last five years, Peritia has completed more than 1,100 engagements for 335 clients worldwide. Peritia \puh-rish-uh\ noun: the state or quality of being experienced. SOURCE Peritia This is a paid placement. For further inquiries, please contact PR Newswire directly.
The Titan Awards, an international advertising competition recognizing extraordinary achievements in healthcare advertising and marketing, honored Amplity as a Platinum Winner for Best Rebranding Effort and a Gold Winner for Best Website Design.
GAINESVILLE, Fla., June 1, 2025 /PRNewswire/ -- The Academy of Oncology Nurse & Patient Navigators (AONN+) is proud to announce the launch of a groundbreaking grant program in partnership with Gilead Sciences aimed at advancing the field of oncology navigation and enhancing patient outcomes within the healthcare setting. This initiative is designed to support the creation, enhancement, and expansion of innovative tools that optimize efficiency and elevate the critical role of oncology navigators.Following the AONN+ call for grant submissions in April, healthcare leaders across the country responded with creative applications, software solution ideas and healthcare system improvements. AONN+ looks to announce the recipients of the award, valued up to $500,000, in June with project work to begin in the July time frame. The AONN+ grant application process and implementation support for awardees also included help from Amplity, AONN+'s association management partner and strategic collaborator."Through this funding mechanism, AONN+ and Gilead are committed to addressing persistent challenges in cancer care by empowering navigators to play a pivotal role in improving patient access to navigation services, removing barriers to cancer care, and supporting treatment adherence," says Candice Roth, MSN, RN, CENP, Executive Director, AONN+. "Navigator utilization continues to present significant opportunities for optimizing patient outcomes, and this program seeks to provide impactful solutions that directly tie proposed tools to measurable improvements in patient care.""As part of Gilead's Community Cancer Collective, we are proud to partner with AONN+ on this exciting initiative in support of the oncology community," said Darren Tayama, M.D., Vice President, US Medical Affairs, Oncology. "Together, AONN+ and Gilead are advancing the future of cancer care through innovative solutions in oncology navigation."About the Academy of Oncology Nurse & Patient Navigators , Inc
Amplity, a full-service partner for outsourcing flexible medical and commercial services, proudly announces the launch of Ava, an AI-powered chatbot designed to deliver faster, more personalized digital experiences on Amplity.com.
Amplity unveils GLP-1 RAs & biologic trends at ISPOR 2025.